\begin{table}[htbp]\centering\begin{tabular}{lccc}\hline
Characteristic & Train & Test & P-value \\
\hline
Number of patients & 1364 & 584 & \\

\makecell[l]{Outcome} & $253.26 \pm 408.56$ & $245.26 \pm 409.81$ & 0.693  \\

\makecell[l]{Gender} & 0: 81.3\%, 1: 18.7\% & 0: 83.0\%, 1: 17.0\% & 0.395  \\

\makecell[l]{First Visit Age} & $22.55 \pm 22.24$ & $22.27 \pm 22.04$ & 0.798  \\

\makecell[l]{CI nd U} & 0: 99.0\%, 1: 1.0\% & 0: 99.3\%, 1: 0.7\% & 0.643  \\

\makecell[l]{Lymphocytes Percentage \\ preclinical} & $38.91 \pm 14.75$ & $38.57 \pm 14.82$ & 0.648  \\

\makecell[l]{Lymphocytes Percentage \\ acute} & $33.07 \pm 14.08$ & $33.64 \pm 14.37$ & 0.411  \\

\makecell[l]{Lymphocytes Percentage \\ chronic} & $35.74 \pm 10.18$ & $35.95 \pm 10.90$ & 0.681  \\

\makecell[l]{Neutrophils Percentage \\ acute} & $58.67 \pm 15.36$ & $58.10 \pm 15.75$ & 0.458  \\

\makecell[l]{Neutrophils Percentage \\ preclinical} & $50.33 \pm 16.11$ & $50.75 \pm 16.29$ & 0.598  \\

\makecell[l]{Neutrophils Percentage \\ chronic} & $54.15 \pm 11.01$ & $53.99 \pm 11.77$ & 0.787  \\

\makecell[l]{Monocytes Percentage \\ acute} & $6.26 \pm 1.10$ & $6.17 \pm 0.99$ & 0.094  \\

\makecell[l]{Monocytes Percentage \\ preclinical} & $6.68 \pm 1.01$ & $6.65 \pm 0.83$ & 0.587  \\

\makecell[l]{Monocytes Percentage \\ chronic} & $6.54 \pm 0.90$ & $6.49 \pm 1.12$ & 0.292  \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin \\ Concentration acute} & $337.20 \pm 11.32$ & $337.53 \pm 15.38$ & 0.598  \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin \\ Concentration chronic} & $333.94 \pm 6.29$ & $333.82 \pm 6.87$ & 0.715  \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin \\ Concentration \\ preclinical} & $343.52 \pm 7.18$ & $343.44 \pm 6.90$ & 0.821  \\

\makecell[l]{Platelet Count acute} & $260.79 \pm 67.12$ & $257.21 \pm 65.91$ & 0.278  \\

\makecell[l]{Platelet Count \\ preclinical} & $252.63 \pm 49.46$ & $254.86 \pm 56.01$ & 0.381  \\

\makecell[l]{Platelet Count chronic} & $256.11 \pm 42.50$ & $252.58 \pm 44.62$ & 0.098  \\

\makecell[l]{White Blood Cell Count \\ chronic} & $8.51 \pm 1.60$ & $8.56 \pm 1.73$ & 0.600  \\

\makecell[l]{White Blood Cell Count \\ acute} & $9.87 \pm 3.05$ & $9.86 \pm 2.80$ & 0.921  \\

\makecell[l]{White Blood Cell Count \\ preclinical} & $8.57 \pm 1.95$ & $8.67 \pm 1.98$ & 0.303  \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin chronic} & $28.89 \pm 1.53$ & $28.85 \pm 1.60$ & 0.648  \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin acute} & $28.60 \pm 1.90$ & $28.64 \pm 2.31$ & 0.753  \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin preclinical} & $28.42 \pm 1.64$ & $28.36 \pm 1.75$ & 0.511  \\

\makecell[l]{Mean Corpuscular Volume \\ preclinical} & $82.89 \pm 5.51$ & $82.76 \pm 5.79$ & 0.643  \\

\makecell[l]{Mean Corpuscular Volume \\ acute} & $84.86 \pm 5.89$ & $84.81 \pm 6.46$ & 0.873  \\

\makecell[l]{Mean Corpuscular Volume \\ chronic} & $86.40 \pm 4.63$ & $86.38 \pm 4.92$ & 0.943  \\

\makecell[l]{Hemoglobin preclinical} & $127.83 \pm 7.51$ & $127.70 \pm 7.87$ & 0.729  \\

\makecell[l]{Hemoglobin chronic} & $130.12 \pm 5.74$ & $129.96 \pm 6.39$ & 0.588  \\

\makecell[l]{Hemoglobin acute} & $129.43 \pm 9.47$ & $129.00 \pm 8.62$ & 0.349  \\

\makecell[l]{Eosinophils Percentage \\ preclinical} & $2.77 \pm 2.60$ & $2.67 \pm 2.27$ & 0.441  \\

\makecell[l]{Eosinophils Percentage \\ acute} & $1.66 \pm 2.10$ & $1.69 \pm 2.04$ & 0.729  \\

\makecell[l]{Eosinophils Percentage \\ chronic} & $2.28 \pm 1.56$ & $2.29 \pm 1.53$ & 0.896  \\

\makecell[l]{Basophils Percentage \\ preclinical} & $0.27 \pm 0.13$ & $0.27 \pm 0.13$ & 0.775  \\

\makecell[l]{Basophils Percentage \\ chronic} & $0.30 \pm 0.16$ & $0.31 \pm 0.19$ & 0.116  \\

\makecell[l]{Basophils Percentage \\ acute} & $0.22 \pm 0.18$ & $0.23 \pm 0.19$ & 0.303  \\

\makecell[l]{Absolute Eosinophil \\ Count acute} & $0.15 \pm 0.22$ & $0.15 \pm 0.18$ & 0.976  \\

\makecell[l]{Absolute Eosinophil \\ Count preclinical} & $0.22 \pm 0.33$ & $0.22 \pm 0.28$ & 0.794  \\

\makecell[l]{Absolute Eosinophil \\ Count chronic} & $0.18 \pm 0.13$ & $0.18 \pm 0.13$ & 0.772  \\

\makecell[l]{Absolute Lymphocyte \\ Count preclinical} & $3.22 \pm 1.34$ & $3.22 \pm 1.35$ & 0.986  \\

\makecell[l]{Absolute Lymphocyte \\ Count acute} & $2.97 \pm 1.30$ & $3.03 \pm 1.31$ & 0.342  \\

\makecell[l]{Absolute Lymphocyte \\ Count chronic} & $2.74 \pm 0.93$ & $2.75 \pm 1.01$ & 0.779  \\

\makecell[l]{Mean Platelet Volume \\ preclinical} & $9.52 \pm 0.83$ & $9.56 \pm 0.78$ & 0.317  \\

\makecell[l]{Mean Platelet Volume \\ chronic} & $9.12 \pm 1.01$ & $9.18 \pm 1.02$ & 0.246  \\

\makecell[l]{Mean Platelet Volume \\ acute} & $9.74 \pm 1.13$ & $9.79 \pm 1.14$ & 0.336  \\

\makecell[l]{Platelet Distribution \\ Width preclinical} & $11.84 \pm 1.51$ & $11.82 \pm 1.54$ & 0.771  \\

\makecell[l]{Platelet Distribution \\ Width acute} & $11.90 \pm 1.86$ & $12.09 \pm 2.07$ & 0.046  \\

\makecell[l]{Platelet Distribution \\ Width chronic} & $12.04 \pm 1.40$ & $12.07 \pm 1.43$ & 0.598  \\

\makecell[l]{Eosinophil Count \\ Absolute chronic} & $180.03 \pm 112.42$ & $178.27 \pm 107.16$ & 0.748  \\

\makecell[l]{Eosinophil Count \\ Absolute acute} & $126.16 \pm 128.48$ & $124.90 \pm 127.90$ & 0.843  \\

\makecell[l]{Eosinophil Count \\ Absolute preclinical} & $236.09 \pm 236.76$ & $231.96 \pm 175.63$ & 0.705  \\

\makecell[l]{CR eactive Protein \\ acute} & $9.55 \pm 9.87$ & $10.15 \pm 10.33$ & 0.227  \\

\makecell[l]{CR eactive Protein \\ chronic} & $5.91 \pm 7.02$ & $5.55 \pm 5.75$ & 0.269  \\

\makecell[l]{CR eactive Protein \\ preclinical} & $8.83 \pm 6.70$ & $9.18 \pm 9.05$ & 0.340  \\

\makecell[l]{Immunoglobulin E acute} & $157.17 \pm 114.82$ & $153.77 \pm 96.85$ & 0.531  \\

\makecell[l]{Immunoglobulin E \\ chronic} & $223.27 \pm 346.60$ & $208.34 \pm 161.69$ & 0.319  \\

\makecell[l]{Free Thyroxine acute} & $15.36 \pm 0.79$ & $15.36 \pm 0.73$ & 0.931  \\

\makecell[l]{Free Thyroxine chronic} & $16.16 \pm 0.92$ & $16.20 \pm 0.90$ & 0.422  \\

\makecell[l]{SMRNP chronic} & $1.21 \pm 0.57$ & $1.30 \pm 2.41$ & 0.208  \\

\makecell[l]{SMRNP acute} & $1.33 \pm 0.55$ & $1.37 \pm 0.86$ & 0.243  \\

\makecell[l]{Anti SSA acute} & $1.10 \pm 2.74$ & $1.31 \pm 4.83$ & 0.232  \\

\makecell[l]{Anti SSA chronic} & $1.32 \pm 2.67$ & $1.35 \pm 3.04$ & 0.834  \\

\makecell[l]{Anti Jo 1 chronic} & $1.08 \pm 0.98$ & $1.05 \pm 0.19$ & 0.437  \\

\makecell[l]{Anti Jo 1 acute} & $0.82 \pm 0.43$ & $0.83 \pm 0.45$ & 0.883  \\

\makecell[l]{Nucleosome acute} & $1.12 \pm 0.74$ & $1.15 \pm 0.74$ & 0.409  \\

\makecell[l]{Nucleosome chronic} & $0.54 \pm 0.44$ & $0.53 \pm 0.44$ & 0.754  \\

\makecell[l]{Ribosomal PP rotein \\ chronic} & $1.22 \pm 2.37$ & $1.17 \pm 0.27$ & 0.580  \\

\makecell[l]{Ribosomal PP rotein \\ acute} & $1.09 \pm 0.28$ & $1.08 \pm 0.27$ & 0.665  \\

\makecell[l]{Ro 52 acute} & $1.79 \pm 1.97$ & $1.94 \pm 4.84$ & 0.330  \\

\makecell[l]{Ro 52 chronic} & $1.83 \pm 2.26$ & $1.88 \pm 3.39$ & 0.702  \\
\hline\end{tabular}\caption{Comparison of the characteristics between the training and testing datasets in the time dependent dataset \\ continuous variables are presented as mean Â± standard deviation, categorical variables are presented as number (percentage)} \label{tab:train_test_time}
\end{table}